EXOGEN

LIVE

Serial Number

75921554

Owner

EXOGEN INC.

Attorney

Michelle M. Mikol

First Use Date

Apr 15, 1993

Filing Date

Feb 17, 2000

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EXOGEN Trademark

Serial Number: 75921554 • Registration: 2508939

EXOGEN is a trademark filed by EXOGEN INC. on February 17, 2000. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

EXOGEN INC. (9 trademarks)

4721 Emperor Boulevard, Suite 100
Durham, NC 27703

Entity Type: 03

BIOVENTUS, LLC (29 trademarks)

DURHAM, NC 27703

Entity Type: 16

SMITH & NEPHEW, INC. (611 trademarks)

1450 BROOKS ROAD
MEMPHIS, TN 38116

Entity Type: 03

Legal Representation

Attorney of Record

Michelle M. Mikol

189 trademarks filed View all →

Correspondence Address

Michelle M. Mikol Barnes & Thornburg LLP

1717 Pennsylvania Avenue N.W.

Washington

DC 20006

UNITED STATES

Trademark Details

Filing Date

February 17, 2000

Registration Date

November 20, 2001

First Use Anywhere

April 15, 1993

First Use in Commerce

April 15, 1993

Published for Opposition

November 21, 2000

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 23, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 23, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 23, 2022 REAP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 23, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 23, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 23, 2022 REAP

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Mar 12, 2021 NA89

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Mar 12, 2021 RNL2

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Mar 12, 2021 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 2, 2021 APRE

TEAS SECTION 8 & 9 RECEIVED

Nov 20, 2020 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Nov 20, 2020 REM2